Anti-PPAR-gamma monoclonal antibody

Pre-made anti-PPAR-gamma monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to PPAR-gamma/PPARG products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T58921-Ab-1/ GM-Tg-hg-T58921-Ab-2Anti-Human PPAR-gamma/PPARG monoclonal antibodyHuman
GM-Tg-rg-T58921-Ab-1/ GM-Tg-rg-T58921-Ab-2Anti-Rat PPAR-gamma/PPARG monoclonal antibodyRat
GM-Tg-mg-T58921-Ab-1/ GM-Tg-mg-T58921-Ab-2Anti-Mouse PPAR-gamma/PPARG monoclonal antibodyMouse
GM-Tg-cynog-T58921-Ab-1/ GM-Tg-cynog-T58921-Ab-2Anti-Cynomolgus/ Rhesus macaque PPAR-gamma/PPARG monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T58921-Ab-1/ GM-Tg-felg-T58921-Ab-2Anti-Feline PPAR-gamma/PPARG monoclonal antibodyFeline
GM-Tg-cang-T58921-Ab-1/ GM-Tg-cang-T58921-Ab-2Anti-Canine PPAR-gamma/PPARG monoclonal antibodyCanine
GM-Tg-bovg-T58921-Ab-1/ GM-Tg-bovg-T58921-Ab-2Anti-Bovine PPAR-gamma/PPARG monoclonal antibodyBovine
GM-Tg-equg-T58921-Ab-1/ GM-Tg-equg-T58921-Ab-2Anti-Equine PPAR-gamma/PPARG monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T58921-Ab-1/ GM-Tg-hg-T58921-Ab-2; GM-Tg-rg-T58921-Ab-1/ GM-Tg-rg-T58921-Ab-2;
GM-Tg-mg-T58921-Ab-1/ GM-Tg-mg-T58921-Ab-2; GM-Tg-cynog-T58921-Ab-1/ GM-Tg-cynog-T58921-Ab-2;
GM-Tg-felg-T58921-Ab-1/ GM-Tg-felg-T58921-Ab-2; GM-Tg-cang-T58921-Ab-1/ GM-Tg-cang-T58921-Ab-2;
GM-Tg-bovg-T58921-Ab-1/ GM-Tg-bovg-T58921-Ab-2; GM-Tg-equg-T58921-Ab-1/ GM-Tg-equg-T58921-Ab-2
Products NameAnti-PPAR-gamma/PPARG monoclonal antibody
Formatmab
Target NamePPAR-gamma
Protein Sub-locationIntrocelluar Protein
Category of antibodyTherapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-PPAR-gamma monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-T58921-Ag-1Recombinant multi-species PPARG/ PPAR-gamma/ CIMT1 protein
    ORF Viral VectorpGMAD000274human PPARG Adenovirus plasmid
    ORF Viral VectorpGMAP000222Human PPARG Adenovirus plasmid
    ORF Viral VectorvGMAP000222Human PPARG Adenovirus particle
    ORF Viral VectorvGMAD000274human PPARG Adenovirus particle
    ORF Viral VectorpGMLV000380rat Pparg Lentivirus plasmid
    ORF Viral VectorpGMAD000070rat Pparg Adenovirus plasmid
    ORF Viral VectorpGMAD000609house mouse Pparg Adenovirus plasmid
    ORF Viral VectorpGMLPm004023mouse Pparg Lentivirus plasmid
    ORF Viral VectorpGMLPm005444mouse Pparg Lentivirus plasmid
    ORF Viral VectorvGMLV000380rat Pparg Lentivirus particle
    ORF Viral VectorvGMAD000070rat Pparg Adenovirus particle
    ORF Viral VectorvGMAD000609house mouse Pparg Adenovirus particle
    ORF Viral VectorvGMLPm004023mouse Pparg Lentivirus particle
    ORF Viral VectorvGMLPm005444mouse Pparg Lentivirus particle
    ORF Viral VectorpGMLV000654chicken PPARG Lentivirus plasmid
    ORF Viral VectorvGMLV000654chicken PPARG Lentivirus particle


    Target information

    Target IDGM-T58921
    Target NamePPAR-gamma
    Gene ID5468,19016,25664,574190,403606,101095161,281993,100051258
    Gene Symbol and SynonymsCIMT1,GLM1,NR1C3,PPAR-gamma,PPAR-gamma2,PPARG,PPARG1,PPARG2,PPARG5,PPARgamma,PPARgamma2
    Uniprot AccessionP37231,O88275,O18924,Q4U3Q4,O18971
    Uniprot Entry NamePPARG_HUMAN,PPARG_MACMU,PPARG_RAT,PPARG_CANLF,PPARG_BOVIN
    Protein Sub-locationIntrocelluar Protein
    CategoryTherapeutics Target
    DiseaseCancer
    Gene EnsemblENSG00000132170
    Target ClassificationNuclear Receptors, Tumor-associated antigen (TAA)

    The target: PPAR-gamma, gene name: PPARG, also named as CIMT1, GLM1, NR1C31, PPARG2, PPARgamma, PPARG. This gene encodes a member of the peroxisome proliferator-activated receptor (PPAR) subfamily of nuclear receptors. PPARs form heterodimers with retinoid X receptors (RXRs) and these heterodimers regulate transcription of various genes. Three subtypes of PPARs are known: PPAR-alpha, PPAR-delta, and PPAR-gamma. The protein encoded by this gene is PPAR-gamma and is a regulator of adipocyte differentiation. Additionally, PPAR-gamma has been implicated in the pathology of numerous diseases including obesity, diabetes, atherosclerosis and cancer. Alternatively spliced transcript variants that encode different isoforms have been described. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.